pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 1·1 min read
save

Study finds statins and blood-pressure meds bring middle-aged obese adults' heart risk markers in line with normal-weight peers

Jul 1, 2026·read at STAT ↗Positive readoutPositive

A new 25-year observational study published in The Lancet shows that adults over 40 with obesity have blood‑pressure and cholesterol levels comparable to those of normal‑weight individuals.

Researchers from the NCD Risk Factor Collaboration tracked cardiovascular risk factors across age and BMI groups, noting that the improvements coincided with broader use of inexpensive statins and antihypertensive drugs rather than newer obesity treatments.

The data indicate that, for middle‑aged and older adults, medication use has narrowed the gap in key heart‑disease risk markers between obese and lean populations, while younger obese adults still exhibit higher risk.

The findings suggest that continued emphasis on managing blood pressure and cholesterol with proven therapies can mitigate some of the cardiovascular dangers associated with obesity, though weight‑related risks remain for younger cohorts.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Statins and blood pressure drugs changing health risks of obesity, study suggests”

read at STAT ↗
1,580 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2
drugs
Obesity26
topics
Obesity29Hematology24Cardiology19Endocrinology & Metabolism5Nephrology5Hypertension3GLP-1 receptor2Hyperlipidemia2Type 2 Diabetes2Heart FailureOncologyOrthopedics

related stories

  • Jul 18Opinion: STAT readers on the value of primary care, obesity as a disease, and moreSTAT
  • Jul 15Deaths from coronary artery disease have fallen, but more progress is within reachSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: AusperBio adds $120M; Abcuro secures $66MFierce Biotech
  • Aug 11Stopping statins in people over 75 at low risk for heart disease didn’t increase deathsSTAT